Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for brand-name prescriptions.

Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal blood sugar.

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their health.